FSPK.F Stock Overview
Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Fisher & Paykel Healthcare Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$22.59 |
| 52 Week High | NZ$25.91 |
| 52 Week Low | NZ$14.64 |
| Beta | 0.37 |
| 1 Month Change | -12.81% |
| 3 Month Change | n/a |
| 1 Year Change | 54.73% |
| 3 Year Change | 19.71% |
| 5 Year Change | 41.36% |
| Change since IPO | 241.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| FSPK.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 21.4% | -0.3% | -2.2% |
| 1Y | 54.7% | 10.0% | 18.3% |
Return vs Industry: FSPK.F exceeded the US Medical Equipment industry which returned 11.1% over the past year.
Return vs Market: FSPK.F exceeded the US Market which returned 20.8% over the past year.
Price Volatility
| FSPK.F volatility | |
|---|---|
| FSPK.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 17.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: FSPK.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine FSPK.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 7,005 | Lewis Gradon | www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary
| FSPK.F fundamental statistics | |
|---|---|
| Market cap | US$11.82b |
| Earnings (TTM) | US$102.59m |
| Revenue (TTM) | US$1.09b |
115.3x
P/E Ratio10.9x
P/S RatioIs FSPK.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FSPK.F income statement (TTM) | |
|---|---|
| Revenue | NZ$1.89b |
| Cost of Revenue | NZ$743.30m |
| Gross Profit | NZ$1.15b |
| Other Expenses | NZ$968.50m |
| Earnings | NZ$178.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
May 27, 2025
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 60.68% |
| Net Profit Margin | 9.44% |
| Debt/Equity Ratio | 3.5% |
How did FSPK.F perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield137%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 06:13 |
| End of Day Share Price | 2025/02/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fisher & Paykel Healthcare Corporation Limited is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |
| Mathieu Chevrier | Citigroup Inc |